SCHEMBL3879480

SCHEMBL3879480

Cc1cccnc1N1CCN(c2cc(-c3ccc(F)cc3)nc(N3CCCC3C)n2)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.42
FAAH O00519 2/20 0.39
TRPV1 Q8NER1 3/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPK1 P28482 1/20 0.39
DYRK1A Q13627 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAP3K12 Q12852 4/20 0.38
KHK P50053 2/20 0.37
PARP1 P09874 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
CXCR4 P61073 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3887559 0.91 SYK (0.43) SYKFAAHTRPV1HSD17B10MAPK1
SCHEMBL3880930 0.91 TRPV1 (0.38) FAAHTRPV1HSD17B10DYRK1AKDM4E
SCHEMBL3878587 0.91 GRM5 (0.41) TRPV1HSD17B10DYRK1AKDM4ELMNA
SCHEMBL14613908 0.89 MAP3K12 (0.39) FAAHTRPV1HSD17B10DYRK1AKDM4E
SCHEMBL3875754 0.88 TRPV1 (0.37) TRPV1DYRK1AMAP3K12KHKPARP1
SCHEMBL3879868 0.88 TRPV1 (0.50) SYKTRPV1HSD17B10MAPK1KHK
SCHEMBL3878207 0.85 GRM5 (0.41) TRPV1HSD17B10DYRK1AKDM4ELMNA
SCHEMBL4929741 0.83 SYK (0.41) SYKHSD17B10MAPK1KDM4ELMNA
SCHEMBL4931600 0.83 MAPK1 (0.39) SYKHSD17B10MAPK1KDM4ELMNA
SCHEMBL3877937 0.83 DYRK1A (0.38) SYKFAAHTRPV1DYRK1AMAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues GPR174, GPR68, PPARG SYK 2406/4885FAAH 1389/4885TRPV1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.